LOS ANGELES, CA–(Marketwired – Dec 16, 2013) – Fresh Start Private Management Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announces the completion of the licensing agreement with JPL, LLC granting them exclusive license and distribution rights of its alcohol treatment program in Connecticut. Under the terms of the executed agreement, JPL, LLC is paying Fresh Start Private an upfront licensing fee and running royalties on program sales in Connecticut for the agreement term. The clinic will operate under the name Start Fresh Recovery and plans to be located around the New Haven area.
This licensing agreement is yet another validation for the treatment program as well as for the Fresh Start Private business model. The company continues to execute on its aggressive growth strategy as shown by the recently announced openings in Northern California, Nebraska, Arizona, and the continued negotiations for the country of Mexico. The Northern California clinic has reported a tremendous amount of activity in its first week.
“The closing of this deal is very important to our short term goal of making our program available to the masses,” said Kent Emry, CEO of Fresh Start Private Management, Inc. “Connecticut is ideally located, as it’s convenient for those in the New York and Boston areas as well. This area of the country is massively populated giving millions better access to our program. JPL reported that they are working diligently to get the clinic opened in Q1 2014. They plan to market the program throughout that massive region until future clinics are opened in neighboring states.”
About Fresh Start Private
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, please visit www.freshstartprivate.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
Investor Relations Contact:
Maximum Performance Advisors, Inc.